A population approach to the forecasting of amikacin plasma and urinary levels using a prescribed dosage regimen

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 24, Issue 1, 1999, Pages 39-46

  Joubert, P ^a   Bressolle, Françoise ^b   Gouby, A ^a   Doucot P Y ^a   Saissi, G ^a   Gomeni, R ^b,c  

^a Hopital Gaston Doumergue   (France)

^b UNIV MONTPELLIER   (France)

^c Zeneca Pharma   (France)

Author keywords

Amikacin; Critically ill patients; Population pharmacokinetics; Serum; Urine

Indexed keywords

AMIKACIN; CREATININE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG URINE LEVEL; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY CLEARANCE; MALE; POPULATION RESEARCH; PREDICTION; RETROSPECTIVE STUDY; STEADY STATE;

EID: 0033031363     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03190009     Document Type: Article

References (22)

1. Kummana C.R., Yuen K.Y. (1994) : Parenteral aminoglycoside therapy. Selection, administration and monitoring. Drugs, 47: 902-913.
2. Gatell J.M., Ferran F., Araujo V., Bonnet M., Soriano E. (1987) : Univariate and multivariate analyses of risk factors predisposing to auditory toxicity in patients receiving aminoglycosides. Antimicrob. Agents Chemother., 31 : 1383-1387.
3. Moore R.D., Smith C.R., Lipsky J.J., Mellits E.D., Lietman P.S. (1984) : Risk factors for nephrotoxicity in patients treated with aminoglycosides. Ann. Intern. Med., 100: 352-367
4. Isaksson B., Nilsson L., Maller R., Soren L. (1988) : Postantibiotic effect of aminoglycosides on Gram-negative bacteria evaluated by a new method. J. Antimicrob. Chemother., 22: 23-33.
5. Marik P.E., Havlik I., Monteagudo F.S.E., Lipma J. (1991) : The pharmacokinetics of amikacin in critically ill adult and paediatric patients: comparison of once-versus twice-daily dosing regimens. J. Antimicrob. Chemother., 27 Suppl. C: 81-89.
6. Gonzalez P., Aguano J.M., Martin M.A., Fernandes-Chacon T., Ortuno B. (1993) : Once daily aminoglycoside dosing. Lancet, 341: 896.
7. Parker S.E., Davey P.G. (1993) : Practicalities of once-daily aminoglycoside dosing. J. Antimicrob. Chemother., 31: 4-8.
8. Belfayol L., Mauran P., Coulaud J.M., Perrin P., Bosio A.M., Fauvelle F. (1995) : Estimations des paramètres pharmacocinétiques de l'amikacine utilisée en dose journalière chez le patient de réanimation. J. Pharm. Clin., 14: 49-52.
9. Erdman S.M., Rodvold K.A., Pryka R.D. (1991) : An updated comparison of drug dosing methods. Part III: aminoglycoside antibiotics. Clin. Pharmacokinet., 20: 374-388.
10. Garraffo R., Iliadis A., Cano J.P., Dellamonica P., Lapalus P. (1989) : Application of bayesian estimation for the prediction of an appropriate dosage regimen of amikacin. J. Pharm. Sci., 78: 753-757.
11. Bressolle F., Gouby A., Martinez J.M. et al. (1996) : Population pharmacokinetics of amikacin in critically ill patients. Antimicrob. Agents Chemother., 40: 1682-1689.
12. Burton M.E., Brater D.C., Chen P.S., Day R.B., Huber P.J., Vasko M.R.A. (1985) : Bayesian feedback method of aminoglycoside dosing. Clin. Pharmacol. Ther., 3: 349-357.
13. Lacarelle B., Granthil L.C., Manelli J.C., Bruder N., François G., Cano J.P. (1987) : Evaluation of a Bayesian method of amikacin dosing in intensive care. Ther. Drug Monit., 9: 155-160.
14. Lenert L.A., Klostermann H., Coleman R.W., Lurie J., Blaschke F. (1992) : Practical computer-assisted dosing for aminoglycoside antibiotics. Antimicrob. Agents Chemother., 36: 1230-1235.
15. Bressolle F., Joubert P., Gouby A., Costa P., Laracine M., Rebière T. (1991) : Altered tobramycin pharmacokinetics during chemoprophylaxis in bladder surgery. Antimicrob. Agents Chemother., 35, 1454-1459.
16. Van der Auwera P. (1991) : Pharmacokinetic evaluation of single daily dose amikacin. J. Antimicrob. Chemother., 27 Suppl. C: 63-71.
17. Beal S.L., Sheiner L.B. NONMEM Users Guide, version 4, University of California at San Francisco, San Francisco, USA.
18. Visual-NM Users Guide, version 2, RDPP, Montpellier, France.
19. Sheiner L.B., Beal S.L. (1981) : Some suggestions for measuring predictive performance. J. Pharmacokinet. Biopharm., 9: 503-512.
20. Sheiner L.B., Beal S.L (1981) : Evaluation of methods for estimating population pharmacokinetic parameters. II. Biexponential model and experimental pharmacokinetic data. J. Pharmacokinet. Biopharm., 9: 635-651.
21. Al-Banna M.K., Kelman A.W., Whiting B. (1990) : Experimental design and efficient parameter estimation in population pharmacokinetics. J. Pharmacokinet. Biopharm., 18: 347-360.
22. Endrenyi L. (1981) : Design of experiments for estimating enzyme and pharmacokinetic experiments. In: Endrenyi L. (Ed.) Kinetic data analysis, design and analysis of enzyme and pharmacokinetic experiments. New York: Plenum, 137-167